Bank of Montreal
SVA

Bank of Montreal’s Sinovac Biotech, Ltd SVA Stock Holding History

Bank of Montreal’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,000
Closed -$10K – 4403
2014
Q3 		$10K Sell
2,000
-2,400
-55% -$12.9K ﹤0.01% 3673
2014
Q2 		$25K Hold
4,400
– – ﹤0.01% 3501
2014
Q1 		$32K Buy
+4,400
New +$29.1K ﹤0.01% 3311

Other funds holding SVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of Montreal's SVA Position: Q4 2014 in Review

Bank of Montreal sold out of Sinovac Biotech, Ltd (SVA) in Q4 2014, closing a stake of 2,000 shares — an estimated $10K sold.

Bank of Montreal first reported a position in SVA in Q1 2014 and held it in 3 quarters. The position peaked at $32K in Q1 2014. 43 funds tracked by Wall St. Rank hold SVA as of Q4 2014.

  • Bank of Montreal reported no remaining Sinovac Biotech, Ltd position as of Q4 2014 after selling out during the quarter.
  • Bank of Montreal sold 2,000 Sinovac Biotech, Ltd shares in Q4 2014, an estimated $10K.
  • Bank of Montreal first reported a position in Sinovac Biotech, Ltd in Q1 2014 and held it in 3 quarters.
  • Bank of Montreal's Sinovac Biotech, Ltd position peaked at $32K in Q1 2014.
  • 43 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q4 2014.

Based on Bank of Montreal's 13F filing for Q4 2014, filed 9 Feb 2015.